雌激素受体 (Estrogen Receptor/ERR) 是一组存在于细胞内的蛋白质。它们是被雌激素(17β-雌二醇)激活的受体。雌激素受体有两种类型:ER,它是细胞内受体的核激素家族的成员;GPER (GPR30),它是 G 蛋白偶联受体的视紫红质样家族的成员。ER 的螺旋 12 结构域在确定与辅激活剂和辅阻遏物的相互作用以及配体的各自激动剂或拮抗剂作用方面起着至关重要的作用。不同的配体对雌激素受体的 α 和 β 同工型的亲和力可能不同:雌二醇与两种受体的结合效果相同,雌酮和雷洛昔芬优先与 α 受体结合,雌三醇,染料木黄酮与 β 受体结合。雌激素及其受体对于性发育和生殖功能至关重要,但也在骨骼等其他组织中发挥作用。雌激素受体还参与乳腺癌、子宫内膜癌和骨质疏松症等病理过程。替代启动子使用和替代剪接导致数十种转录变体,但其中许多变体的全长性质尚未确定。
Estrogen receptors are a group of proteins found inside cells. They are receptors that are activated by the hormone estrogen (17β-estradiol). Two classes of estrogen receptor exist: ER, which is a member of the nuclear hormone family of intracellular receptors, and GPER (GPR30), which is a member of the rhodopsin-like family of G protein-coupled receptors. The ER's helix 12 domain plays a crucial role in determining interactions with coactivators and corepressors and, therefore, the respective agonist or antagonist effect of the ligand. Different ligands may differ in their affinity for alpha and beta isoforms of the estrogen receptor: estradiol binds equally well to both receptors, estrone, and raloxifene bind preferentially to the alpha receptor, estriol, and genistein to the beta receptor. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative promoter usage and alternative splicing result in dozens of transcript variants, but the full-length nature of many of these variants has not been determined.
(R)-OP-1074 是 OP-1074 (MS-T56877) 的异构体,可作为实验中的对照化合物;OP-1074 是一种纯抗雌激素药,也是一种选择性 ER 降解剂 (PA-SERD),对 ERα 和 ERβ 具有特异性抗雌激素活性,可抑制 17β-estradiol (E2) 刺激的转录活性,IC50 分别为 1.6 和 3.2 nM。
10-Chloroestra-1,4-diene-3,17-dione(10-CIEsra)是一种雌激素受体衍生物。
Raloxifene dimethyl ester hydrochloride(Compound 28)是一种 Raloxifene 类似物,详细信息请参考专利文献 US5464845A 中的化合物 28。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号